Biomeme Labs
Inflammation Compass™ Results

Understanding Your Cellular Results

Your personal dashboard delivers quantitative molecular insights across the 3 Inflammation Compass™ Health Domains plus cellular deconvolution — from initial baseline reference to longitudinal cellular trajectories.

Report Architecture

Your Molecular
Report Decoded

Every Biomeme Labs report establishes a personal molecular baseline and tracks longitudinal gene expression across testing nodes — building an objective picture of your immune system's active biological response.

Pillar 01 Node 1 Reference

Personal Baseline Reference Map

Your molecular starting point. Whole-blood RNA-seq profiling captures your personal gene expression levels across all pathways before or upon entering monitoring. Because no two immune systems idle at the same level, your baseline establishes the personal benchmark against which all future progress is measured.

Personal Reference Benchmark Healthy Cohort Calibration Within-Sample Rank Scoring
Pillar 02 Longitudinal Follow-up

Dynamic Multi-Domain Profile

Your real-time molecular picture — reporting active gene expression across the 3 Health Domains (Activation, Antiviral Response, and Resolution) alongside Cellular Deconvolution. Updated at each testing node to track quantitative trendlines, trajectory arrows, and cellular shifts.

Activation (7 Pathways) Antiviral (S1–S4 Modules) Resolution (2 Pathways) Cellular Deconvolution
Mathematical Foundation

Why We Never Collapse Your Results into a Single Composite Score

In conventional medicine, laboratory tests frequently collapse complex biological signals into a solitary number. In the Inflammation Compass™, each domain is scored independently (0–100 percentile rank) using within-sample gene ranking. High Activation with robust Resolution represents a working, adapting immune defense; high Activation with flat Resolution represents an incomplete program. Collapsing these independent signals would erase the very insight you need.

The Complete Biological Choreography

The Nine-Stage
Inflammatory Arc

Inflammation is not an enemy or a disease — it is a vital, self-limiting biological program designed to protect, contain, clean, and restore. Health is not the absence of inflammation; it is an immune system that activates when challenged and actively completes the arc.

The Fundamental Mechanism of Chronic Inflammation: The Incomplete Arc

Medical science historically treated chronic inflammation as “too much activation.” Contemporary immunology reveals that chronic inflammation is almost always a failure of active resolution. When the body encounters persistent metabolic stress or obesity, it initiates Stages 1–5 (Detect through Eliminate), but stalls before engaging Stages 6 & 7 (Stop and Clean). Switching off inflammation requires active, energy-consuming molecular programs (macrophage M2 repolarization, specialized pro-resolving mediators, and efferocytosis). When resolution machinery is deficient, the immune system stays stuck in a destructive loop.

01 Activation

Detect

Pattern recognition receptors (such as Toll-like receptors TLR2 and TLR4) on circulating monocytes and tissue sentinels sense danger signals (DAMPs) and metabolic stress.

02 Activation

Alert

Intracellular transcriptional alarms fire: NF-κB activates, broadcasting the emergency via gene transcription of inflammatory cytokines including IL-1β, TNF-α, and IL-6.

03 Activation

Mobilize

Chemokines (MCP-1/CCL2) and endothelial adhesion molecules (ICAM-1, VCAM-1) recruit monocytes and neutrophils into circulation; the liver synthesizes acute-phase proteins (CRP).

04 Activation

Contain

Platelet activation and local microvascular barriers isolate the stressor, walling off tissue to prevent systemic dissemination of cellular damage or pathogens.

05 Act / Antiviral

Eliminate

Frontline phagocytes (neutrophils and inflammatory monocytes) deploy oxidative bursts, enzymatic digestion, and effector killing to destroy the threat.

06 Resolution

Stop (Active Stand-Down)

Active regulatory checkpoint brakes engage. Lipid mediator class switching occurs (lipoxins, resolvins), pro-inflammatory signaling is halted, and macrophages polarize toward an M2 resolving state.

07 Resolution

Clean (Efferocytosis)

Resolving macrophages ingest and clear billions of apoptotic neutrophils and cellular debris without causing tissue destruction (non-phlogistic clearance), preventing secondary tissue necrosis.

08 Tissue Recovery

Repair

Local tissue remodeling machinery takes over: fibroblast activation, extracellular matrix reconstruction, microvascular capillary restoration, and tissue architecture rebuilding.

09 Longitudinal Memory

Learn

Epigenetic chromatin remodeling and cellular immune memory record the experience — including the durable epigenetic memory retained by human adipocytes following metabolic weight loss.

The Conventional Testing Resolution Blind Spot

Conventional Blood Labs (hs-CRP & CBC) Only measure downstream echoes of Stages 2 & 3 (Alert & Mobilize). When hs-CRP falls, it tells you the alarm bell stopped ringing, but reveals zero information on whether Stages 6 & 7 (Stop & Clean) were successfully executed or if low-grade smoldering activity persists.
Inflammation Compass™ (Whole-Blood RNA) Measures gene expression across the full arc — quantifying the frontline myeloid alarm (Activation Domain) alongside the active regulatory checkpoint and efferocytosis machinery (Resolution Domain), providing a 360° view of healing.
Translating Biology into Action

Real-World Clinical Scenarios &
Longitudinal Trajectories

How members and their healthcare providers evaluate transcriptomic trendlines across real-world situations — from weight stalls and rapid titration to protocol tapering.

Scenario A Node 2 (~1 Month)

The Scale Stall with Hidden Calming

Weight Plateau • Active Biological Engagement

Clinical Context: A member at Week 8 experiences a 4-week plateau on the bathroom scale. Frustrated and discouraged, they consider abandoning therapy.

Transcriptomic Pattern: Activation domain drops sharply from the 78th to the 32nd percentile (Settling). Resolution domain rises from 25th to 64th percentile (Active). Leukocyte deconvolution confirms monocyte quieting.

Clinical Value: Objective cellular proof that downstream metabolic and vascular calming is actively occurring despite the scale stall. Reassures member and provider to maintain course.

Trajectory: Settling / Resolving Reassurance to stay the course
Scenario B Node 3 (~3 Months)

Aggressive Deficit with Stress Rebound

Rapid Weight Loss • Rising Stress Activation

Clinical Context: Rapid scale loss (3–4 lbs/week) driven by severe caloric restriction. The member reports heavy fatigue, brain fog, and muscle weakness.

Transcriptomic Pattern: Activation domain rebounds from 30th to 68th percentile (Rising / Primed), marked by neutrophil degranulation and stress-axis cortisol signaling. Resolution remains flat (28th percentile).

Clinical Value: Alerts member and prescriber that excessive caloric restriction or overtraining is creating catabolic stress. Prompts clinician to review protein intake, pacing, and recovery.

Trajectory: Rising / Primed Prompt to review nutrition & pacing
Scenario C Node 4 (Maintenance / Off-Ramp)

The Off-Ramp Taper Surveillance Checkpoint

Protocol Tapering • Long-Term Homeostasis

Clinical Context: After 12 months, target metabolic goals are achieved. In consultation with their physician, the member decides to taper or space their dosage.

Transcriptomic Pattern: Pre-taper benchmark establishes steady state. A follow-up test 3–6 months post-taper confirms whether Resolution remains high and Activation stays settled.

Clinical Value: Provides an objective biological surveillance window to ensure anti-inflammatory equilibrium is self-sustaining, guarding against the silent rebound driven by adipose epigenetic memory.

Trajectory: Autonomous Equilibrium Surveillance against adipose memory
Scenario D Cellular Intelligence

Demographics vs. Activation (Deconvolution)

Cell Census vs. Cellular Orders

Clinical Context: A routine complete blood count shows elevated white blood cells, leaving the member concerned about widespread infection or inflammatory relapse.

Transcriptomic Pattern: Reference-based cellular deconvolution reveals that while neutrophil fraction is elevated (demargination from vascular walls), per-cell inflammatory gene expression is low and quiescent.

Clinical Value: Solves the bulk tissue confound by clearly differentiating “more cells present in blood” from “cells actively running hotter,” avoiding unnecessary alarms.

Census vs. Orders Decoupled Prevents false alarms
Your 4-Node Journey

The Testing Cadence:
Track Your Trends

Inflammation Compass™ is structured as a 4-node test series. Each node builds on the last, creating a longitudinal molecular trajectory that evolves with your therapy.

Node 1 Day 0

Baseline Profile

Your Initial Starting Reference

Your initial molecular baseline. Whole-blood RNA-seq establishes your personal starting reference profile across all 3 Health Domains and cellular deconvolution — whether drawn before your first dose or upon entering monitoring while on therapy.

Node 2 ~1 Month (~4 Weeks)

Initial Response

Early Downstream Quieting

Early confirmation of downstream systemic calming. Pathway analysis verifies whether innate inflammatory signaling is settling and active resolution programs are engaging — delivering clarity even during early scale plateaus.

Node 3 ~3 Months (~12 Weeks)

Steady State

Therapeutic Equilibrium

Longitudinal transcriptomic assessment verifies whether your immune system has reached a stable, calm equilibrium under steady therapy or protocol dosing, evaluating consolidated metabolic reprogramming.

Node 4 12+ Months / Off-Ramp

Annual Maintenance & Off-Ramp

Autonomous Resolution Surveillance

Ongoing maintenance monitoring tracks cellular stability and resolution tone during long-term maintenance or protocol tapering — guarding against inflammatory relapse driven by adipose tissue epigenetic memory.

Actionable Insights

What To Discuss With
Your Healthcare Provider

Your molecular data surfaces meaningful biological patterns. Share these objective trendlines with your prescribing clinician to inform care evaluations.

Lean Mass Preservation

Systemic Calming & Anabolic Environment

Direct muscle changes are monitored with clinical body composition scans (such as DXA) and supported with progressive resistance training and adequate dietary protein. Inflammation Compass verifies that systemic inflammatory stress is resolving — fostering an anabolic-permissive environment that protects functional lean mass.

Read Lean Mass Guide →

Calming During Scale Stalls

Downstream Innate Immune Calming

If bathroom scale weight plateaus or moves slowly, whole-blood transcriptomics at Node 2 reveals whether downstream innate inflammatory pathways and metabolic stress programs are actively resolving. Share this objective molecular progress with your provider.

Read Clinical Response Guide →

Personalized Protocol Context

Objective Biological Clarity

Transcriptomic data reveals cellular shifts weeks before traditional lagging blood chemistry (like hs-CRP) or physical changes reflect downstream outputs. Discuss these longitudinal trends with your clinician when reviewing your overall therapeutic protocol.

Explore All Biomarkers →
Your Dashboard

Track Your
Molecular Journey

Your results live in a secure, personal web application — not a static PDF. Log in to explore your data, track trends, and watch your molecular picture evolve with each testing node.

Secure Access

Encrypted, HIPAA-aligned digital web application. Your molecular data is completely private and accessible only to you.

Baseline & Longitudinal

View your initial molecular baseline alongside dynamic mRNA gene expression trends over time, all in one unified interface.

Health Domain Trending

Track how scores evolve across Activation, Antiviral Response, and Resolution domains. Each testing node adds to your longitudinal trajectory.

Smart Notifications

Receive secure notifications when new laboratory results are ready. Download clinician summaries to bring to your appointments.

Start Your Monitoring
Journey Today

Starting at $600 for your baseline assessment package (includes Node 1 Baseline and Node 2 Initial Response) — stranded RNA-seq, mobile phlebotomy, and full dashboard access included.

Direct-access ordering available across 42 states (excludes CA, CT, MA, MD, NJ, NY, PA, and RI).